JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Our novel findings of CML cell death induced by disrupting Bcr-Abl/Jak2/HSP90 HMWNC through treatment with a HSP90 inhibitor reveals the critical role of HSP90 in stabilizing this HMWNC that maintains leukemic state.